PIPgene_en

PIPgen: a new Innovative Training Network to put PI3K/PTEN related diseases under the spotlight PIPgen brings together 9 leading European basic and clinical institutions and 3 private companies experts in the PI3K/PTEN field, to train 15 researchers at the Phd level...

ONCOPOLE_en

ONCOPOLE – Functional analysis of the inherited N363K POLE mutation in highly aggressive colon cancers and glioblastomas In rare cases, the occurrence of cancer is linked to an inherited genetic mutation, in which case there is a familial predisposition. Several...

MITHAML_en

MITHAML – Metabolic heterogeneity in acute myeloid leukaemia Accumulating evidence indicates that metabolism is involved in the drug resistance that develops in acute myeloid leukaemia (AML). However, approaches have so far assessed metabolism as a whole,...

PROTEOblood_en

PROTEOblood : Development of new therapies against two subtypes of lymphoma and leukaemia. Significant progress has recently been made in the diagnosis and selective treatment of certain blood cancers. However, most of these malignancies remain incurable. There is...

MEDIRAD_en

MEDIRAD – Consequences of medical exposure to low dose radiation The evolution of medical science and the increasing pace of innovation and deployment of medical technology have led to a situation where the majority of artificial ionising radiation exposure to...

PINICAL-MRT_en

PINICAL-MRT : Clinical impact protocols in molecular radiotherapy Development of guidelines to translate knowledge on molecular radiotherapy into clinical practice Article 56 of the EC Directive 2013/59/EURATOM, detailing the requirements for individual dose planning...

Pin It on Pinterest

Centre de Recherches en Cancérologie de Toulouse
Privacy Policy

To improve your browsing experience. Cookies provide information on how the site is used: statistics such as the number of visitors, the average length of visits or the number of pages viewed. On the other hand, disabling cookies may prevent you from using certain features, such as sharing content via social networks.
By clicking "Accept", you agree to the use of cookies from this site and to our privacy policy.

You can adjust all your cookie settings by navigating the tabs on the left.